Comparative Pharmacology
Head-to-head clinical analysis: METHADOSE versus OXYCODONE AND ASPIRIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: METHADOSE versus OXYCODONE AND ASPIRIN.
METHADOSE vs OXYCODONE AND ASPIRIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Methadone is a mu-opioid receptor agonist; it also acts as an NMDA receptor antagonist and inhibits serotonin and norepinephrine reuptake, contributing to its analgesic and detoxification effects. It has a long half-life and reduces opioid craving and withdrawal symptoms.
Oxycodone: mu-opioid receptor agonist; Aspirin: irreversible cyclooxygenase (COX-1 and COX-2) inhibitor, reducing prostaglandin synthesis.
Oral: 20-40 mg once daily, titrated to effect; for opioid dependence, typical maintenance 80-120 mg/day. IV: 2.5-10 mg every 8-12 hours.
1 tablet (oxycodone 4.5 mg/aspirin 325 mg) orally every 6 hours as needed for pain; maximum 4 tablets in 24 hours.
None Documented
None Documented
Terminal elimination half-life range: 8–59 hours (mean ~20–35 hours). In chronic use, half-life may increase due to accumulation. Context: The long half-life supports once-daily dosing for opioid dependence but requires careful titration to avoid accumulation.
Oxycodone: 3-5 hours (immediate-release); 4.5-8 hours (extended-release). Aspirin (salicylate): 2-3 hours (low dose), 15-30 hours (high dose due to saturation of metabolic pathways).
Primarily renal (approximately 80%) as inactive metabolites, with about 20% eliminated via feces. Less than 10% excreted unchanged.
Oxycodone: renal (primarily as noroxycodone) 87%, fecal <10%. Aspirin (as salicylate): renal 50-80% (dose-dependent; alkaline urine increases excretion), with biliary elimination of metabolites.
Category C
Category D/X
Opioid Agonist
Opioid Agonist